The health system has used IT to improve care outcomes for its diabetic population, double the number of HIV and HCV screenings for at-risk patients and reduce drug-resistant infections.
These initiatives have produced a return on investment of nearly $8 million.
“As an integrated care delivery network serving patients regardless of their ability to pay, MetroHealth’s commitment to prevention and chronic disease management is critical to avoid hospitalizations and reduce costs,” said Jonathan French, director of quality and patient safety at HIMSS North America. “What many organizations call ‘soft return on investment’ associated with improved patient outcomes has a real impact on the bottom line for MetroHealth.”
More articles on health IT:
Unlocking the value of patient portals: 3 thoughts from athenahealth
When patients can and can’t access their medical records
Stanford Medicine dean: Instead of precision medicine, let’s focus on precision health
